Stock Market Today: Sensex, Nifty Halt Six-Day Winning Run As Traders Await Fed Decision
The local currency appreciated about 6 paise to close at 81.83 against the greenback on Wednesday.
It closed at 81.89 on Tuesday.
Source: Bloomberg
Revenue up 10% at Rs 5,841.72 crore vs Rs 5,304.82 crore
Ebitda up 58% at Rs 853.56 crore vs Rs 540.2 crore
Ebitda margin at 14.6% vs 10.2%
Net profit up 106% at Rs 340.67 crore vs Rs 165.21 crore
Source: Exchange filing
Axis Bank clarified the media reports regarding credit exposure to Go First.
Bank ascertained that it has no fund-based or non-fund-based outstanding left with Go First, as of date.
Source: Exchange filing
Revenue up 24% at Rs 1,646.27 crore vs Rs 1,330.64 crore (Bloomberg estimates: Rs 1,016.3 crore)
Ebitda up 34% at Rs 346.01 crore vs Rs 257.98 crore (Bloomberg estimates: Rs 245.8 crore)
Ebitda margin at 21% vs 19.4% (Bloomberg estimates: 24.2%)
Net profit up 75% at Rs 453.87 crore vs Rs 258.65 crore (Bloomberg estimates: Rs 350.9 crore)
Source: Exchange filing
Bank of Baroda has appointed Debadatta Chand as Managing Director and Chief Executive Officer for a period of three years from July 1.
Debadatta Chand was the Executive Director of Bank of Baroda since March 3' 2021.
He has over 28 years of experience in Commercial Banks and Developmental Financial Institutions.
He is also on the Board of BOB Capital Markets Ltd., India Infradebt Ltd., Baroda Financial Solutions Ltd., Bank of Baroda (Tanzania) Ltd., Bank of Baroda (Uganda) Ltd. and Bank of Baroda (Kenya) Ltd.
Source: Exchange filing
The broader market indices opened higher and outperformed the larger peers; S&P BSE MidCap Index was up by 0.39%, whereas S&P BSE SmallCap Index was higher by 0.35%.
Twelve out of the 20 sectors compiled by BSE declined, eight sectors advanced in trade.
The market breadth was skewed in the favour of the buyers. About 1,840 stocks rose 1576 declined, and 144 remained unchanged on the BSE.
Revenue down 7% at Rs 13872.64 crore Vs Rs 14917.26 crore (BBG Estimate: Rs 16,011.7 crore)
Net profit down 60% at Rs 93.61 crore Vs Rs 234.29 crore (BBG Estimate: Rs 281.3 crore)
EBITDA down 16% to Rs 358.7 crore Vs Rs 425.72 crore (BBG Estimate: Rs 533.2 crore)
Margins at 2.6% Vs 2.9% (BBG Estimate: 3.3%)
Source: BSE Filing
Shares of the non-banking financial company dropped by 4.98% to Rs 118.3 apiece, as of 10.35 a.m., as compared to the decline in the benchmark, NSE Nifty 50 Index by 0.19%.
The stock fell as much as 4.98% intraday so far; the lowest since April 13 and recorded no movement since the market opened.
Total traded volume stood at 2.6 times its 30-day average.
Out of the 2 analysts tracking the company, one maintains a 'buy' rating, while the other suggests to 'sell' the stock, according to Bloomberg data.
The return potential as calculated by the consensus of analyst estimates, stand at an upside of 50.5% over the next 12 months.
To utilise better cash accruals from operations and hive-off of cargo business along with government's Emergency Credit Line Guarantee Scheme for it.
Already mobilised close to RS 400 crore for it.
Source: Press Release
HDFC Kick-Starts $1 Billion Credila Sale By Picking Jefferies As Adviser, Sources Say
The broader market indices opened higher and outperformed the larger peers; S&P BSE MidCap Index was up by 0.06%, whereas S&P BSE SmallCap Index was higher by 0.14%.
Twelve out of the 20 sectors compiled by BSE declined, eight sectors advanced in trade.
The market breadth was skewed in the favour of the buyers. About 1,361 stocks rose 1,051 declined, and 110 remained unchanged on the BSE.
Source: BSE
At pre-open, the S&P BSE Sensex Index was down 81 points or 0.13% at 61,273.70 while the NSE Nifty 50 Index was lower by 34 points or 0.19% at 18,113.80.
Source: Bloomberg
The yield on the 10-year bond declined 2 bps to open at 7.07% on Wednesday.
It closed at 7.09% on Tuesday.
Source: Bloomberg
The local currency appreciated about 12 paise to open at 81.77 against the greenback on Wednesday.
It closed at 81.89 on Tuesday.
Source: Bloomberg
U.S. drug regulator issued zero observations under form 483 after concluding an inspection at InvaGen Pharmaceuticals Inc.'s facility in Massachusetts.
The inspection was conducted at Cipla's subsidiary from April 24 to May 1, 2023.
Source: Exchange filing
Gravita India's step down subsidiary Gravita Netherlands BV has been provided 34 million Euros ( Rs 306.34-crore) ESG loan from European Developmental Financial Institutions.
The loan was provided after due diligence on various environmental, social and governance aspects at the company's manufacturing subsidiaries.
The loan is a testament towards the company's commitment to sustainability and circular economy.
Source: Exchange filing
Asian Stocks Decline As Bank Woes Hit US Shares: Markets Wrap
Karnataka Elections 2023: PM Modi Campaign To Ensure BJP Majority, Says Rajeev Chandrasekhar
AI Disruption Deepens With Chegg Plunge, IBM Hiring Halt, Samsung Chatbot Ban
I&B Ministry Calls For Curb On Outdoor Ads Of Betting, Gambling Platforms
EPFO Extends Deadline To Apply For Higher Pension Till June 26
Cash-Starved Go First Awaits Clearer Flight Path With Insolvency Resolution Hopes
Go First Says Forced To File Bankruptcy Due To 'Enormous Damage' By Engine Supplier
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
